11 March 2024

READ MOREAkston Biosciences’ AKS-107 Study Published in Frontiers in Immunology, Displaying Ambifect® Platform’s Versatility

26 February 2024

READ MOREAkston Biosciences’ AKS-452 Vaccine Study Published in Nature, Showcasing Ambifect® Platform’s Versatility

31 August 2023

READ MOREAkston Biosciences Receives 2023 Most Innovative Award at Animal Health Summit

28 August 2023

READ MOREAkston Biosciences CEO to Present at the 2023 Animal Health Summit in Kansas City

17 August 2023

READ MOREAkston Biosciences to Focus on Strong Animal Health Pipeline

9 March 2023

READ MOREAkston Biosciences Strengthens Board with Addition of John T. Preston

9 February 2021

READ MOREAkston Biosciences Completes Second Licensing and Supply Agreement with Dechra Pharmaceuticals PLC

22 July 2020

READ MOREAkston Biosciences Receives $2.5M Milestone Payment

9 April 2020

READ MOREAkston Biosciences Completes Series E Preferred Stock Financing

2 August 2019

READ MOREAkston Biosciences Completes Licensing and Supply Agreement with Dechra Pharmaceuticals PLC